Epigenomics at 360° in Liquid Biopsy: Approaches and Case Studies for Biomarker Discovery and Drug Development
Dr. Matteo Tosolini and Dr. Jessica Apulei from Hologic Diagenode answer questions from their webinar on epigenomics as a dynamic regulatory layer beyond genetics and liquid biopsies as a means of obtaining multimodal biomarker readouts.
Epigenomics at 360° in Liquid Biopsy: Approaches and Case Studies for Biomarker Discovery and Drug Development
In this talk, we highlight epigenomics as a dynamic regulatory layer beyond genetics and demonstrate how minimally invasive liquid biopsies can provide multimodal biomarker readouts.
Reprogramming Mouse Fibroblasts Into Induced Cardiomyocytes: Age-Related, Metabolic, and Epigenetic Barriers
Join Dr. Sandrina Nóbrega-Pereira as she discusses the role of age, epigenetics, and mitochondrial metabolism in the Direct Cardiac Conversion (DCC) of fibroblasts into induced cardiomyocytes (iCMs).
Circulating Nucleosome Quantification (Nu.Q®) Technology for Monitoring Target Engagement and Adverse Events in Oncology Trials
Join us for a comprehensive webinar featuring experts in epigenetics and assay development, focusing on the scientific foundations and applications of Nucleosome Quantification (Nu.Q®) Technology in the realms of drug development and disease monitoring.
Chronological Age vs Biological Age: Can Aging be Reversed?
What can biological age tell us about our health? Is it a fixed number, or can it be reduced? A recent study from Poganik et al. investigates the fluctuations in biological age in response to physiological stress.
